Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
11376
Hoya Capital High Dividend Yield ETF
RIET
$99M
| $105K | ﹤0.01% |
+10,404
| New | +$111K |
2024 Q4
0 quarters
|
|
|
LUNA
11377
PUT
DELISTED
Luna Innovations Incorporated
LUNA
| $105K | ﹤0.01% |
+48,600
| New | +$86K |
2024 Q4
0 quarters
|
|
11378
PUT
Arbutus Biopharma
ABUS
$850M
| $105K | ﹤0.01% |
32,100
-3,600
| -10% | -$13.2K |
2020 Q3
17 quarters
|
|
|
WLACU
11379
DELISTED
Willow Lane Acquisition Corp Unit
WLACU
| $105K | ﹤0.01% |
+10,517
| New | +$105K |
2024 Q4
0 quarters
|
|
|
CUB
11380
Lionheart Holdings
CUB
$285M
| $105K | ﹤0.01% |
+10,375
| New | +$104K |
2024 Q4
0 quarters
|
|
11381
PUT
Invesco S&P 500 GARP ETF
SPGP
$2.07B
| $105K | ﹤0.01% |
1,000
-1,000
| -50% | -$108K |
2023 Q1
7 quarters
|
|
11382
PUT
HCI Group
HCI
$2.32B
| $105K | ﹤0.01% |
+900
| New | +$103K |
2024 Q4
0 quarters
|
|
11383
Apyx Medical
APYX
$107M
| $105K | ﹤0.01% |
66,355
+53,782
| +428% | +$75.2K |
2024 Q2
2 quarters
|
|
11384
CALL
Kiniksa Pharmaceuticals
KNSA
$6.08B
| $105K | ﹤0.01% |
5,300
-4,400
| -45% | -$100K |
2020 Q2
18 quarters
|
|
11385
CALL
ProShares UltraShort Euro
EUO
$35.6M
| $105K | ﹤0.01% |
3,000
-5,600
| -65% | -$184K |
2024 Q2
2 quarters
|
|
|
CTLP
11386
PUT
DELISTED
Cantaloupe
CTLP
| $105K | ﹤0.01% |
11,000
+4,100
| +59% | +$37.3K |
2021 Q1
15 quarters
|
|
11387
CALL
Freedom Holding
FRHC
$11.1B
| $105K | ﹤0.01% |
800
-1,000
| -56% | -$115K |
2022 Q4
8 quarters
|
|
11388
GeoVax Labs
GOVX
$2.63M
| $104K | ﹤0.01% |
+1,691
| New | +$97.9K |
2024 Q4
0 quarters
|
|
11389
PUT
Invesco Leisure and Entertainment ETF
PEJ
$358M
| $104K | ﹤0.01% |
2,000
| – | – |
2024 Q1
3 quarters
|
|
11390
PUT
UroGen Pharma
URGN
$1.99B
| $104K | ﹤0.01% |
9,800
-39,400
| -80% | -$472K |
2022 Q4
8 quarters
|
|
|
CVAC
11391
CALL
DELISTED
CureVac
CVAC
| $104K | ﹤0.01% |
30,600
+7,400
| +32% | +$21.3K |
2020 Q3
17 quarters
|
|
|
MAPS
11392
DELISTED
WM TECHNOLOGY INC A
MAPS
| $104K | ﹤0.01% |
+75,610
| New | +$81.3K |
2024 Q4
0 quarters
|
|
|
CCIRU
11393
DELISTED
Cohen Circle Acquisition Corp. I Unit
CCIRU
| $104K | ﹤0.01% |
+10,306
| New | +$103K |
2024 Q4
0 quarters
|
|
11394
PUT
Quanex
NX
$843M
| $104K | ﹤0.01% |
4,300
+3,500
| +438% | +$100K |
2022 Q4
8 quarters
|
|
11395
Mobix Labs
MOBX
$22.3M
| $104K | ﹤0.01% |
+6,127
| New | +$62.4K |
2024 Q4
0 quarters
|
|
11396
PUT
Ardagh Metal Packaging
AMBP
$2.63B
| $104K | ﹤0.01% |
34,500
+28,900
| +516% | +$104K |
2021 Q4
12 quarters
|
|
|
CIO
11397
CALL
DELISTED
City Office REIT
CIO
| $104K | ﹤0.01% |
18,800
-9,000
| -32% | -$49.4K |
2023 Q4
4 quarters
|
|
|
VCICU
11398
DELISTED
Vine Hill Capital Investment Corp Unit
VCICU
| $104K | ﹤0.01% |
+10,283
| New | +$103K |
2024 Q4
0 quarters
|
|
|
RYZ
11399
PUT
Ryerson Holding Corp
RYZ
$1.36B
| $104K | ﹤0.01% |
5,600
-4,000
| -42% | -$89.8K |
2021 Q1
15 quarters
|
|
|
CCRN
11400
PUT
DELISTED
Cross Country Healthcare
CCRN
| $104K | ﹤0.01% |
5,700
+3,600
| +171% | +$48.5K |
2022 Q3
9 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.